Patents
Sitemap › C07 - Organic chemistry › C07C - Acyclic or carbocyclic compounds › C07C 311 - Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
Patents for C07C 311 - Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups (17,647)
12/2003
12/30/2003CA2051399C Therapeutically useful 2-aminotetralin derivatives
12/25/2003US20030236231 Polycyclic aryl and heteroaryl substituted benzenes useful for selective inhibition of the coagulation cascade
12/25/2003US20030235779 Photoacid generating compounds, chemically amplified positive resist materials, and pattern forming method
12/24/2003WO2003106428A1 Novel arylsulphonamide derivatives and use thereof as therapeutic agents
12/24/2003WO2003106419A1 Room-temperature molten salt, process for producing the same and applications thereof
12/24/2003WO2003106410A1 Fluorinated cycloalkyl-derivatised benzoylguanidines and their use as a medicament
12/24/2003WO2003106405A1 Aspartyl protease inhibitors
12/24/2003WO2003106402A1 2-naphtamide derivatives
12/24/2003WO2002046147A3 Perturbed membrane-binding compounds
12/24/2003WO2002018540A3 Pyridine derivatives useful as cd40:cd154 binding interruptor compounds and use thereof to treat immunological complications
12/24/2003CN1131855C 1－取代－1－氨基甲基－环烷衍生物(=加巴喷丁类似物)、其制备及其在治疗神经病方面的用途 L-amino-1-substituted methyl - naphthenic derivative (= gabapentin analogs), their preparation and their use in the treatment of neuropathy
12/24/2003CA2489286A1 2-naphtamide derivatives
12/24/2003CA2489245A1 Fluorinated cycloalkyl-derivatized benzoylguanidines and their use as a medicament
12/24/2003CA2489095A1 Aspartyl protease inhibitors
12/23/2003US6667404 Retroviral protease inhibiting compounds
12/23/2003US6667377 Having pendant groups containing fluorosulfonyl methide or fluorosulfonyl imide derivatives and univalent metal salts thereof; electrochemical applications such as batteries, fuel cells, electrolysis cells
12/23/2003US6667342 Benzenesulfonamide-derivatives and their use as medicaments
12/23/2003US6667331 Non-peptidyl inhibitors of VLA-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases
12/18/2003WO2003103660A1 Substituted phenylsulfonamide inhibitors of beta amyloid production
12/18/2003WO2003103651A1 Compounds of the formu;a r1-x-y-z-nr2r3 as abca-1 elevating agents against cad or atherosclerosis
12/18/2003WO2003103599A2 Caspase-1 inhibitors and methods for their use
12/18/2003WO2003074467A3 Urea derivatives as hiv aspartyl protease inhibitors
12/18/2003WO2003072537A3 Selective protein tyrosine phosphatatase inhibitors
12/18/2003US20030233015 Sulfonamide derivatives
12/18/2003US20030232863 Cathepsin cysteine protease inhibitors
12/18/2003US20030232838 6-phenylpyrrolopyrimidinedione derivatives
12/18/2003US20030232830 Non-covalent inhibitors of AmpC beta-lactamase
12/18/2003US20030232815 Non-peptidic cyclophilin binding compounds and their use
12/18/2003US20030232811 Anthranilic acid derivative
12/18/2003US20030232012 For use as in vivo contrast media in nuclear spin tomography (MRT), as blood-pool agents and as lymphographic agents
12/18/2003CA2486581A1 Substituted phenylsulfonamide inhibitors of beta amyloid production
12/17/2003EP1370522A1 Phenyl derivatives and their use in the treatment of thromboembolic disorders or tumours
12/17/2003EP1370521A1 Formanilide derivatives as beta2-adrenoreceptor agonists
12/17/2003EP1370520A1 Aryl and biaryl compounds having mch modulatory activity
12/17/2003EP1370510A2 Hiv integrase inhibitors
12/17/2003EP1370255A2 Cdc25 phosphatase inhibitors
12/17/2003EP1278718B1 Novel amino acid derivatives, preparation method, compositions containing same and uses thereof as sunscreens
12/17/2003EP1100775B1 2,5-substituted benzolsulfonylureas and thioureas, methods for the production thereof, use thereof and pharmaceutical preparations containing the same
12/17/2003CN1462268A Substituted cinnamic acid guanidides, method for the production thereof, their use as medicament, and medicine containing these compounds
12/16/2003US6664400 1-((4-halo-3-sulfonamidophenyl)aminocarbonyl),2-carboxy -pyrrolidine intermediate of given formula
12/16/2003US6664291 Malonamic acids and derivatives thereof as thyroid receptor ligands
12/16/2003US6664259 Il-8 receptor antagonists
12/11/2003WO2003101948A2 Agents for imaging and diagnostic methods using them
12/11/2003WO2003101943A1 Heat sensitive recording material
12/11/2003WO2003101442A1 Peptide deformylase inhibitors
12/11/2003WO2003101382A2 Compounds useful in the treatment of anthrax and inhibiting lethal factor
12/11/2003WO2003101381A2 1,2 diamido cycloalkyl sodium channel blockers
12/11/2003WO2003048117A3 Propanolaminomethyltetralines, their preparation and pharmaceutical composition comprising same
12/11/2003US20030229228 Plant safening agents; fungicides
12/11/2003US20030229138 Aza hydroxylated ethyl amine compounds utility
12/11/2003US20030229102 Sulfonamide derivatives
12/11/2003US20030229093 Lipid diseases; metabolism diosrders; antiproliferative agents
12/11/2003US20030229083 Compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them
12/11/2003US20030229054 Novel amines as pharmaceutical agents
12/11/2003US20030229053 Compounds and methods for the treatment or prevention of flavivirus infections
12/11/2003CA2488219A1 Agents for imaging and diagnostic methods using them
12/11/2003CA2486770A1 Heat sensitive recording material
12/10/2003EP1368325A1 New asymmetric process for the preparation of diarylmethylpiperazines derivatives and novel asymmetric diarylmetylamines as intermediates
12/10/2003EP1056710B1 Diterpene derivatives and anti-inflammatory analgesic agents comprising the same
12/10/2003EP0933346B1 NOVEL p-TERPHENYL COMPOUNDS
12/09/2003US6660885 Polycyclic aryl and heteroaryl substituted benzenes useful for selective inhibition of the coagulation cascade
12/09/2003US6660884 Catalysts, methods for making said catalysts, and methods for making chiral compounds with high enantioselectivity
12/09/2003US6660879 Use of the compound in clinical conditions associated with insulin resistance.
12/04/2003WO2003099776A1 Calcium receptor modulating arylalkylamines
12/04/2003WO2003099773A1 Ccr9 inhibitors and methods of use thereof
12/04/2003WO2003099772A1 Phenylcyclohexylpropanolamine derivatives, preparation and therapeutic application thereof
12/04/2003WO2003099765A1 β-ALANINE DERIVATIVE AND USE THEREOF
12/04/2003WO2003099192A2 Bis-aromatic alkanols
12/04/2003WO2003072062A3 Amino-substituted (e)-2,6-dialkoxystyryl 4-substituted benzylsulfones for treating proliferative disorders
12/04/2003WO2003057169A3 4-dedimethylamino tetracycline compounds
12/04/2003WO2003034989A3 α-HYDROXYARYLBUTANAMINE INHIBITORS OF ASPARTYL PROTEASE
12/04/2003US20030225285 Oxidizing a protected aminoalcohol to a chiral protected aminoaldehyde and diastereoselectively forming the aminoepoxide from said aminoaldehyde with an organometallic methylene-adding reagent in an appropriate solvent
12/04/2003US20030225266 N-aromatic or heteroaromatic-oxyalkylene, hydrocarbylnamide derivatives useful for potentiating glutamate receptor function; Alzheimer's Disease; antidepressants; cognition activators; psychosis; psychiatric and neurological disorders
12/04/2003US20030225163 Sulfonamide derivatives
12/04/2003US20030225091 Aryl carboxylic acids and tetrazoles for treating diabetes, especially type II diabetes
12/04/2003US20030225084 Have an affinity for the gabapentin binding site and can be used to treat conditions such as pain, epilepsy, migraine and others.
12/04/2003US20030225074 E.g., 2-((4'-Methoxy(1,1'-biphenyl)-4-yl)sulfonyl)amino-4-hydroxy-5-((2 -thiazolyl)thio)-pentanoic Acid
12/04/2003US20030225053 N-arylcarboxamides of fused ring systems including naphthalenes, benzothiophenes, benzofurans and indoles
12/04/2003US20030225043 Especially for inhibiting type IV collagenase
12/04/2003US20030224940 Alpha-sulfin-and alpha-sulfonamino acid amide derivatives
12/04/2003CA2784937A1 Ccr9 inhibitors and methods of use thereof
12/04/2003CA2486853A1 Bis-aromatic alkanols
12/03/2003EP1366023A2 Water- and oil-repellency imparting ester oligomers comprising perfluoroalkyl moieties
12/03/2003EP1170287B1 Process for preparation of optically active n-substituted azetidine-2-carboxylic acids
12/03/2003CN1129576C Phenyl heterocyclic compound used as epoxy enzyme-2 inhibitor
12/03/2003CN1129428C Endothelin receptor antagonists
12/02/2003US6656971 Non-peptidic small organic compounds having an affinity for cyclophilin (CyP)-type immunophilins; inhibiting their peptidyl-prolyl isomerase activity; treating variety of medical conditions
12/02/2003US6656965 HIV protease inhibitors based on amino acid derivatives
12/02/2003CA2244785C Pentafluorobenzenesulfonamides and analogs
11/2003
11/27/2003WO2003097576A2 Diamino-functional chalcones
11/27/2003WO2003097575A2 Amino-functional chalcones
11/27/2003WO2003097574A2 Aminoalkoxy-functional chalcones
11/27/2003WO2003097568A1 Process for producing 4-phenyl-4-oxo-2-butenoic ester derivative
11/27/2003WO2003014064A8 Naphthylurea and naphthylacetamide derivatives as vanilloid receptor 1 (vr1) antagonists
11/27/2003WO2002057242A3 Urea derivatives as integrin alpha 4 antagonists
11/27/2003US20030220508 An enzyme inhibitor for treating AIDS, viral infections
11/27/2003US20030220468 Modified forms of pharmacologically active agents and uses therefor
11/27/2003US20030220367 Administering a therapeutical carbamate derivative to a patient as prostaglandin IP (12 or PGI2) antagonists
11/27/2003US20030220350 For example, 3-(4-((N-(5-chlorobenzo(B)thiophen-3-carbonyl)-N-(2,2-diphenyl ethyl)amino)methyl)benzoylamino)propionic acid; for treatment or prevention of glucagon-mediated diseases such as diabetes
11/26/2003EP1363878A1 Process for preparing sulfamoyl-substituted phenethylamine derivatives
1 ... 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 ... 177